CVS Pharmacy and related subsidiaries agree to pay $315 million to settle a U.S. Justice Department case involving allegations that the company unlawfully dispensed opioid prescriptions that were medically unnecessary. The DOJ says CVS also sought reimbursement for many of the prescriptions through federal health care programs, according to multiple outlets.

The settlement resolves the government’s efforts to hold companies accountable amid the U.S. opioid and overdose crisis, as several reports note. The disputes described across sources include a DOJ lawsuit and references to earlier whistleblower litigation under the False Claims Act. One outlet highlights that a related matter traces back to a complaint filed in 2019 by a former CVS employee, while others focus on the DOJ lawsuit filed in 2024.

Overall, the coverage converges on the settlement amount and the core allegations: inappropriate dispensing of opioids and other controlled substances and subsequent billing/reimbursement. The reports vary mainly in emphasis—some stress the False Claims Act whistleblower angle, while others focus on the DOJ’s later filing and the federal health care reimbursement component.